West Pharmaceutical Services EBITDA 2010-2024 | WST

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

West Pharmaceutical Services 2023 EBITDA was 0.813B, a 4.83% decline from 2022.
West Pharmaceutical Services 2022 EBITDA was 0.855B, a 2.29% decline from 2021.
West Pharmaceutical Services 2021 EBITDA was 0.875B, a 69.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

West Pharmaceutical Services 2023 EBITDA was 0.813B, a 4.83% decline from 2022.
West Pharmaceutical Services 2022 EBITDA was 0.855B, a 2.29% decline from 2021.
West Pharmaceutical Services 2021 EBITDA was 0.875B, a 69.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.